Market Overview

UPDATE: Jefferies Raises PT to $38 on ICON plc; Strategic Partnerships Paying Off

Share:
Related ICLR
Earnings Scheduled For February 25, 2015
Top 4 NASDAQ Stocks In The Medical Laboratories & Research Industry With The Highest EPS

Jefferies maintained ICON plc (NASDAQ: ICLR) with a Buy rating and raised the price target from $33.50 to $38.00.

Jefferies analyst David Windley noted, "Bookings growth over the last year has accelerated, after trailing peers prior to mid-'11. Backlog conversion has dropped with that acceleration in bookings, falling below 11% initially, but is now rebounding. The company is in earlier stages of a maturation process that sees its business focus increasingly on a shorter list of very large clients. It is investing in IT system integration and shared service centers to support those clients."

ICON plc closed at $31.74 on Monday.

Latest Ratings for ICLR

DateFirmActionFromTo
Apr 2015BarclaysMaintainsEqual-weight
Mar 2015SunTrust Robinson HumphreyMaintainsBuy
Feb 2015JefferiesMaintainsBuy

View More Analyst Ratings for ICLR
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (ICLR)

Around the Web, We're Loving...